𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Low intensity laser therapy in the treatment of temporomandibular disorders: a double-blind study

✍ Scribed by R. DE ABREU VENANCIO; C. M. CAMPARIS; R. DE FÁTIMA ZANIRATO LIZARELLI


Book ID
108881540
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
103 KB
Volume
32
Category
Article
ISSN
0305-182X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Treatment of postmastectomy lymphedema w
✍ Colin J. Carati; Sandy N. Anderson; Bren J. Gannon; Neil B. Piller 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

## Abstract ## BACKGROUND The current study describes the results of a double blind, placebo‐controlled, randomized, single crossover trial of the treatment of patients with postmastectomy lymphedema (PML) with low‐level laser therapy (LLLT). ## METHODS Participants received placebo or one cycle

Double-blind, placebo-controlled investi
✍ Basim Mokhtar; Dr. G. David Baxter; Deirdre M. Walsh; A. Jean Bell; James M. All 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 750 KB

## Background and objective: This study assessed the putative analgesic effect of combined monochromatic light/laser irradiation at low intensity (660-950 nm; 31.9 j/cm2; pulsed at 16 or 73 hz). ## Study design/materials and methods: The investigation was completed under double-blind conditions u

Alprazolam in the treatment of generaliz
✍ G. Chouinard; L. Annable; R. Fontaine; L. Solyom 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 472 KB

In a double-blind controlled study lasting 8 weeks, 50 anxious psychoneurotic outpatients with a primary diagnosis of generalized anxiety or panic disorder were randomly assigned to alprazolam (n = 30), a new benzodiazepine, or placebo (n = 20), after a washout period of 1 week. Alprazolam at dosage

Imipramine in the treatment of bulimia:
✍ Agras, W. Stewart ;Dorian, Barbara ;Kirkley, Betty G. ;Arnow, Bruce ;Bachman, Jo 📂 Article 📅 1987 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 506 KB

There were 22 bulimic women who participated in a double-blind placebo-controlled study of the effects' of imipramine hydrochloride in the treatment of bulimia over a 16 week period. Participants receiving the active drug demonstrated a significantly greater reduction in purging (frequency of self-i